World Journal of
Pharmaceutical and Life Sciences

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Life Sciences
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
World Journal of Pharmaceutical and Life Sciences (WJPLS) has indexed with various reputed international bodies like : Google Scholar, Index Copernicus, Indian Science Publications, SOCOLAR, China, Cosmos Impact Factor, Research Bible, Fuchu, Tokyo. JAPAN, Scientific Indexing Services (SIS), Jour Informatics (Under Process), UDLedge Science Citation Index, Global Impact Factor (In Process), International Impact Factor Services, International Scientific Indexing, UAE, International Society for Research Activity (ISRA) Journal Impact Factor (JIF), Science Library Index, Dubai, United Arab Emirates, International Innovative Journal Impact Factor (IIJIF), Scientific Journal Impact Factor (SJIF), Eurasian Scientific Journal Index (ESJI), Indian citation Index (ICI), IFSIJ Measure of Journal Quality, International Scientific Indexing, UAE (ISI), Web of Science Group (Under Process), Directory of Research Journals Indexing, Scholar Article Journal Index (SAJI), International Scientific Indexing ( ISI ), Scope Database, 

Abstract

A REVIEW ON NOVEL THERAPEUTIC OPTIONS FOR THE TREATMENT OF TUBERCULOSIS IN THE COMMUNITY

Thanakanti Bhargavi*, A. Bharath Kumar, S. Kavya, Thota Srimannarayana, Shaik Mohammad Sohail, D. Jothieswari

ABSTRACT

Tuberculosis is a common cause of death and illness across the world. To reduce the worldwide impact of tuberculosis, early identification of the infection and early identification of therapeutic resistance is necessary. Although authorised diagnostic procedures like as culture, direct microscopy, bio-molecular assays, and whole genome sequencing are available, their general usage is typically limited due to prices, local resources, time restrictions, and operator efficiency. The susceptibility pattern of the isolate found determines which medication regimen should be used. The advancements in the treatment of tuberculosis lead to the development of novel therapeutic protocols including in the near future. By strengthening existing diagnostic and treating procedures, promoting prevention measures, increasing government commitment and greater funding, and accelerating research and innovation, the End-TB Strategy launched by WHO intends to significantly reduce the trouble of Tuberculosis on its way to global extinction. A variety of newer medications and therapeutic techniques are useful for the treatment of tuberculosis in the community.

[Full Text Article]

BEST PAPER AWARDS

World Journal of Pharmaceutical and life sciences Will give best paper award in every issue in the from of money along with certificate to promote research .

Best Article of current issue

Download Article : Click here